Tafenoquine (Prevention of Malaria Relapse) and Urocit-K 5 Oral
Determining the interaction of Tafenoquine (Prevention of Malaria Relapse) and Urocit-K 5 Oral and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
Generic Name: potassium citrate
Brand name: Urocit-K
Synonyms: Potassium, Potassium Citrate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Tafenoquine (Prevention of Malaria Relapse)-Urofollitropin
- Tafenoquine (Prevention of Malaria Relapse)-Urofollitropin Intramuscular, Subcutaneous, Injection
- Tafenoquine (Prevention of Malaria Relapse)-Urogesic-Blue
- Tafenoquine (Prevention of Malaria Relapse)-Urokinase
- Tafenoquine (Prevention of Malaria Relapse)-Urokinase Intravenous
- Tafenoquine (Prevention of Malaria Relapse)-Urolet MB
- Urocit-K 5 Oral-Tafenoquine Succinate (Arakoda)
- Urocit-K 5 Oral-Tafenoquine Succinate (Krintafel)
- Urocit-K 5 Oral-Tafinlar
- Urocit-K 5 Oral-Tafluprost
- Urocit-K 5 Oral-Tafluprost ophthalmic
- Urocit-K 5 Oral-Tagamet